We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$916M
AUM Growth
+$6.2M
Cap. Flow
-$44.4M
Cap. Flow %
-4.85%
Top 10 Hldgs %
39.79%
Holding
139
New
22
Increased
30
Reduced
39
Closed
21

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$29M
2
LNG icon
Cheniere Energy
LNG
+$12.6M
3
UNH icon
UnitedHealth
UNH
+$12.4M
4
MU icon
Micron Technology
MU
+$11.4M
5
META icon
Meta Platforms (Facebook)
META
+$10.9M

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$24.4M
2
LRCX icon
Lam Research
LRCX
+$24.1M
3
PANW icon
Palo Alto Networks
PANW
+$20.3M
4
DKNG icon
DraftKings
DKNG
+$14.5M
5
DXCM icon
DexCom
DXCM
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 25.27%
2 Consumer Discretionary 17%
3 Healthcare 15.63%
4 Communication Services 9.56%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
101
Boston Scientific
BSX
$63.6B
$693K 0.08%
9,000
ACHC icon
102
Acadia Healthcare
ACHC
$2.55B
$631K 0.07%
9,340
STWD icon
103
Starwood Property Trust
STWD
$5.63B
$542K 0.06%
28,600
-66,879
-70% -$1.3M
HOLX
104
DELISTED
Hologic
HOLX
$532K 0.06%
7,160
ONON icon
105
On Holding
ONON
$8.94B
$495K 0.05%
+12,745
New +$466K
FANG icon
106
Diamondback Energy
FANG
$59.2B
$491K 0.05%
2,454
-14,212
-85% -$2.82M
VICI icon
107
VICI Properties
VICI
$27.3B
$473K 0.05%
16,500
GILD icon
108
Gilead Sciences
GILD
$181B
$432K 0.05%
6,300
PRU icon
109
Prudential Financial
PRU
$41.2B
$387K 0.04%
3,300
ARGX icon
110
argenx
ARGX
$61.3B
$385K 0.04%
895
NKE icon
111
Nike
NKE
$53.7B
$362K 0.04%
+4,800
New +$446K
BRK.B icon
112
Berkshire Hathaway Class B
BRK.B
$1.11T
$322K 0.04%
791
-3,968
-83% -$1.62M
HUM icon
113
Humana
HUM
$47.6B
$306K 0.03%
820
-26,960
-97% -$9.1M
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$12.5B
$295K 0.03%
3,580
PL icon
115
Planet Labs
PL
$5.83B
$267K 0.03%
+143,338
New +$275K
ACLX
116
DELISTED
Arcellx
ACLX
$265K 0.03%
+4,800
New +$261K
INFN
117
DELISTED
Infinera Corporation Common Stock
INFN
$248K 0.03%
+40,800
New +$216K
ITCI
118
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$233K 0.03%
+3,400
New +$236K
ACN icon
119
Accenture
ACN
$118B
-16,946
Closed -$5.87M
BLBD icon
120
Blue Bird Corp
BLBD
$1.96B
-16,263
Closed -$624K
BTG icon
121
B2Gold
BTG
$6.9B
-59,600
Closed -$156K
CSCO icon
122
Cisco
CSCO
$434B
-11,500
Closed -$574K
DKNG icon
123
DraftKings
DKNG
$12.2B
-318,762
Closed -$14.5M
DXCM icon
124
DexCom
DXCM
$32.6B
-102,357
Closed -$14.2M
FERG icon
125
Ferguson
FERG
$41.6B
-111,850
Closed -$24.4M

Similar funds

Clough Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Clough Capital Partners held 139 positions worth $916M, up 0.68% from $910M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Clough Capital Partners withdrew a net $44.4M in Q2 2024, closing 21 positions and reducing 39 holdings. Its most notable exit was Ferguson, an estimated $24.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Clough Capital Partners opened a new position in Meta Platforms (Facebook) worth $11.3M.

  • Clough Capital Partners's largest Q2 2024 buy was Meta Platforms (Facebook): 22,487 shares worth $11.3M.
  • Clough Capital Partners added most to Apple in Q2 2024, an estimated $29M increase.
  • Clough Capital Partners's biggest Q2 2024 reduction was Lam Research, cutting an estimated $24.1M.
  • Clough Capital Partners fully exited Ferguson in Q2 2024, selling an estimated $24.4M.
  • Clough Capital Partners's ten largest holdings make up 40% of its $916M portfolio in Q2 2024.
  • Clough Capital Partners opened 22 new positions and closed 21 in Q2 2024.
  • Clough Capital Partners's portfolio value rose 0.68% quarter-over-quarter to $916M.

Based on Clough Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.